Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.5800
-0.0251 (-4.15%)
May 6, 2026, 2:22 PM EDT - Market open
Cytosorbents Market Cap
Cytosorbents has a market cap or net worth of $36.37 million as of May 6, 2026. Its market cap has decreased by -46.60% in one year.
Market Cap
36.37M
Enterprise Value
60.80M
1-Year Change
-46.60%
Ranking
Category
Stock Price
$0.58
Market Cap Chart
Since December 23, 2014, Cytosorbents's market cap has decreased from $194.60M to $36.37M, a decrease of -81.31%. That is a compound annual growth rate of -13.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 37.90M | -5.49% |
| Dec 31, 2025 | 40.10M | -19.48% |
| Dec 31, 2024 | 49.80M | 1.01% |
| Dec 29, 2023 | 49.30M | -27.07% |
| Dec 30, 2022 | 67.60M | -62.90% |
| Dec 31, 2021 | 182.20M | -47.05% |
| Dec 31, 2020 | 344.10M | 175.72% |
| Dec 31, 2019 | 124.80M | -51.19% |
| Dec 31, 2018 | 255.70M | 37.10% |
| Dec 29, 2017 | 186.50M | 34.37% |
| Dec 30, 2016 | 138.80M | -1.77% |
| Dec 31, 2015 | 141.30M | -38.99% |
| Dec 31, 2014 | 231.60M | 19.01% |
| Dec 23, 2014 | 194.60M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accuray | 55.00M |
| Baird Medical Investment Holdings | 54.22M |
| InspireMD | 54.05M |
| Envoy Medical | 53.44M |
| Pulmonx | 53.22M |
| PAVmed | 48.57M |
| TELA Bio | 46.53M |
| Elutia | 44.21M |